Eurofins Expands Dungarvan Facilities
Eurofins Lancaster Laboratories, a part of Eurofins Scientific, has announced the expansion of its Dungarvan campus. The expansion includes a new building and an expansion of existing facilities.
Eurofins Lancaster Laboratories, a part of Eurofins Scientific (Paris, France), has announced the expansion of its Dungarvan campus (Ireland). The expansion includes a new building and an expansion of existing facilities.
“This expansion is the result of successfully growing strategic partnerships with our clients and the value we bring to them and their target markets,” said Timothy S. Oostdyk, Chairman, Eurofins Lancaster Laboratories, and Group Senior Vice President, Eurofins BioPharma Product Testing.
Building works are expected to commence in the fourth quarter of 2016 and will expand the existing facilities from a 2700 m2 laboratory to a 9000 m2 facility, focused on the biopharmaceutical industry in Ireland and the UK.
Carmel Fitzpatrick, Managing Director of Eurofins Lancaster Laboratories, Ireland, highlighted the commitment and technical capabilities of Eurofins staff. “We invest heavily in our internal training programmes, and we are grateful to be supported by the IDA and the Skillnets to deliver technical competency in our team that is world class,” commented Fitzpatrick.
The expansion will increase Eurofins Dungarvan based workforce to over 500 by 2021, including the 175 new jobs created within the past 24 months. An achievement not lost on Mary Mitchell O’Connor, Minister for Jobs, Enterprise, and Innovation who enthused, “It’s great to see an established successful company like Eurofins expanding its operations further in Waterford.”
For more information about Eurofins, please visit www.eurofins.com
The Next Frontier for Mass Spectrometry: Maximizing Ion Utilization
January 20th 2025In this podcast, Daniel DeBord, CTO of MOBILion Systems, describes a new high resolution mass spectrometry approach that promises to increase speed and sensitivity in omics applications. MOBILion recently introduced the PAMAF mode of operation, which stands for parallel accumulation with mobility aligned fragmentation. It substantially increases the fraction of ions used for mass spectrometry analysis by replacing the functionality of the quadrupole with high resolution ion mobility. Listen to learn more about this exciting new development.
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
PFAS Identified in Smartwatch and Fitness Bands Using LC–MS/MS
January 28th 2025“Forever chemicals” per- and polyfluoroalkyl substances (PFAS) have been found in smartwatch and fitness bands and analyzed using liquid chromatography tandem mass spectrometry (LC–MS/MS) and direct total oxidative precursor (dTOP) assay.
